CRBP vs TFC · $102.3M cap vs rev $11.82B
Corbus Pharmaceuticals Holding (CRBP) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
TFC (TFC) common stock.
CRBP does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
CRBP currently screens at market cap $102.3M. TFC currently screens at market cap $0.
Not investment advice. Open the CRBP and TFC stock pages for the full models.
Not investment advice.